{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:13Z","timestamp":1791618973635,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1006\/gyno.2000.5839","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"309-312","source":"Crossref","is-referenced-by-count":76,"title":["Gestational Trophoblastic Disease: A Study of Mode of Evacuation and Subsequent Need for Treatment with Chemotherapy"],"prefix":"10.1006","volume":"78","author":[{"given":"J.A.","family":"Tidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Radstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.5839_RF1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1471-0528.1979.tb10694.x","article-title":"An analysis of the influences of maternal age, gestational age, contraceptive method and the mode of primary treatment of patients with hydatiform moles on subsequent chemotherapy","volume":"86","author":"Stone","year":"1979","journal-title":"Br J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5839_RF2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(86)90179-0","article-title":"Hydatidiform mole in England and Wales 1973\u20131983","volume":"ii","author":"Bagshawe","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/gyno.2000.5839_RF3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0028-2243(91)90161-D","article-title":"Medical induction prior to surgical evacuation of hydatiform mole: is there a greater risk of presistent trophoblastic disease?","volume":"42","author":"Flam","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1006\/gyno.2000.5839_RF4","series-title":"Gestational Trophoblastic Disease","first-page":"175","article-title":"Investigation and Treatment of Patients with Persistent Gestational Trophoblastic Disease and Gestational Trophoblastic Tumors in the UK","author":"Newlands","year":"1997"},{"key":"10.1006\/gyno.2000.5839_RF5","series-title":"Gestational Trophoblastic Disease","first-page":"213","article-title":"Difference in management and treatment: a critical appraisal","author":"Hancock","year":"1997"},{"key":"10.1006\/gyno.2000.5839_RF6","first-page":"139","article-title":"Current management of complete and partial molar pregnancy","volume":"39","author":"Goldstein","year":"1994","journal-title":"J Reprod Med"},{"key":"10.1006\/gyno.2000.5839_RF7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy","volume":"331","author":"Jain","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2000.5839_RF8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-0528.1974.tb00363.x","article-title":"Extra amniotic prostaglandins in the management of intrauterine death, anenecphaly and hydatidiform mole","volume":"81","author":"Embrey","year":"1974","journal-title":"J Obstet Gynecol Br Commonw"},{"key":"10.1006\/gyno.2000.5839_RF9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1471-0528.1974.tb00434.x","article-title":"Simultaneous intravenous infusion of prostaglandin E2 (PGE2) and oxytocin in the management of intrauterine death of the fetus, missed abortion and hydatidiform mole","volume":"81","author":"Naismith","year":"1974","journal-title":"J Obstet Gynecol Br Commonw"},{"key":"10.1006\/gyno.2000.5839_RF10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-0528.1972.tb12910.x","article-title":"Termination of second trimester pregnancy with 15 methyl analogues of prostaglandin E2 and F2","volume":"79","author":"Karim","year":"1972","journal-title":"J Obstet Gynecol Br Commonw"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800958396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800958396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T03:53:23Z","timestamp":1557374003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825800958396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0090825800958396"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.5839","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}